Companies: 11,396     total market cap: โ‚น13976.750 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Alnylam Pharmaceuticals
ALNY
#1146
Rank
โ‚น1.904 T
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น14,219
Share price
-3.33%
Change (1 day)
-63.69%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

EPS for Alnylam Pharmaceuticals (ALNY)

EPS in 2023 (TTM): -โ‚น337.24

According to Alnylam Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is โ‚น1,861. In 2022 the company made an earnings per share (EPS) of -โ‚น872.50 a decrease over its 2021 EPS that were of -โ‚น676.21.

EPS history for Alnylam Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น337.24-61.35%
2022-โ‚น872.5029.03%
2021-โ‚น676.21-3.36%
2020-โ‚น699.69-8.48%
2019-โ‚น764.497.67%
2018-โ‚น710.0239.74%
2017-โ‚น508.1012.94%
2016-โ‚น449.8738.84%
2015-โ‚น324.02-32.88%
2014-โ‚น482.74259.44%
2013-โ‚น134.30-31.25%
2012-โ‚น195.3552.94%
2011-โ‚น127.7330.77%
2010-โ‚น97.67-8.77%
2009-โ‚น107.0778.12%
2008-โ‚น60.11-70.78%
2007-โ‚น205.6899.09%
2006-โ‚น103.31-43.88%
2005-โ‚น184.08-82.33%
2004-โ‚น1,042-59.23%
2003-โ‚น2,556

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น493.07-73.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น178.72-90.39%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
โ‚น3,936 111.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น247.00-113.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น68.56-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น8.45-100.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น59.17-96.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
-โ‚น312.75-116.81%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com